Health & Fitness
Health and Fitness
Health and Fitness
Fri, August 20, 2010
Thu, August 19, 2010
Biomagnetics Announces Webinar by Los Alamos National Security, LLC
SAN FRANCISCO--([ BUSINESS WIRE ])--Biomagnetics Diagnostics Corp., (PINK SHEETS:[ BMGP ]) a developer of revolutionary diagnostic systems and other innovative technologies, today announced that Dr. Harshini Mukundan, Scientist at Los Alamos National Laboratories (aLANLa) will be presenting a technical awebinar,a or web-based seminar, to scientific attendees on the Integrated Optical Biosensor Development (IOBS) technology developed at LANL. Those affiliated with BMGP are welcome to attend.
Biomagnetics has entered into a Patent License Agreement and Collaborative Research and Development Agreement (CRADA) with Los Alamos National Security, LLC. Under the agreements, Biomagnetics will have access to the IBOS technology. BMGPa™s initial focus will be on tuberculosis, cholera and malaria diagnosis.
Clayton Hardman, CEO of Biomagnetics, stated that he and Dr. Mukundan recently completed a trip to India that included meeting with the Director General of Health Services, R.K. Srivastava, the Tuberculosis Research Centre and the National Institute of Malaria Research. The purpose of these meetings was to establish the ground rules for collaboration leading to successful conclusion of clinical trials.
The webinar will explore the genesis of the IOBS Unit as well as a simplified technical review of the system versus current diagnostic methodology.
WHEN: Friday, August 27, 2010
TIME and LINK: To follow
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer other innovative technologies. The Companya™s revolutionary diagnostic systems, which are based on advanced waveguide and magnetics technologies, can test for all viral or bacterial diseases. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies. Additionally, the Company is currently developing a waveguide-based advanced integrated optical biosensor through its collaborative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at [ www.biomagneticsbmgp.com ].
